olsalazine has been researched along with Cancer of Pelvis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Collins, RT; Deming, RL; Frank, AR; Hyland, G; Mailliard, JA; Martenson, JA; Moertel, CG; Moore, RL; Morton, RF; O'Fallon, JR; Tewfik, HH; Urias, RE | 1 |
1 trial(s) available for olsalazine and Cancer of Pelvis
Article | Year |
---|---|
Olsalazine is contraindicated during pelvic radiation therapy: results of a double-blind, randomized clinical trial.
Topics: Aged; Aminosalicylic Acids; Contraindications; Defecation; Diarrhea; Double-Blind Method; Drug Administration Schedule; Female; Humans; Incidence; Male; Pelvic Neoplasms; Spasm | 1996 |